CT-P13

CT-P13 is a biosimilar medication that closely resembles infliximab, a biologic drug used to treat inflammatory conditions like rheumatoid arthritis and Crohn's disease. It works by targeting a protein called TNF-alpha, which plays a key role in inflammation. As a biosimilar, CT-P13 offers a similar safety and effectiveness profile at a potentially lower cost, providing patients and healthcare providers with an alternative option to the original medication. It is rigorously tested to ensure it matches the original in quality, safety, and efficacy.